Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Trial Designed to Evaluate a New Critical Pathway for Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections

NCT02961764 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02961764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02961764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Trial Designed to Evaluate a New Critical Pathway for Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
November 29, 2016
Completion date
March 29, 2019
Enrollment
313 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute bacterial skin and skin structure infections